CCNB1 and colorectal carcinoma: CCNA2, CCNB1, CDK1, CKS2, DLGAP5, and MAD2L1 are correlated with the pathological CRC stage which means that they may be useful as new independent prognostic biomarkers in predicting the clinical treatment effect in CRC patients.